Filtros : "Solid-state characterization" Limpar

Filtros



Refine with date range


  • Source: Journal of Pharmaceutical Sciences. Unidade: IFSC

    Subjects: CRISTALOGRAFIA, DIFRAÇÃO POR RAIOS X

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BORGES, Bruno Arantes et al. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate. Journal of Pharmaceutical Sciences, v. No 2024, n. 11, p. 3297-3303 + supplementary materials, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2024.08.025. Acesso em: 03 jan. 2026.
    • APA

      Borges, B. A., Reis, K. de S., Pinto, C. B., Ellena, J., Doriguetto, A. C., & Bonfilio, R. (2024). A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate. Journal of Pharmaceutical Sciences, No 2024( 11), 3297-3303 + supplementary materials. doi:10.1016/j.xphs.2024.08.025
    • NLM

      Borges BA, Reis K de S, Pinto CB, Ellena J, Doriguetto AC, Bonfilio R. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate [Internet]. Journal of Pharmaceutical Sciences. 2024 ; No 2024( 11): 3297-3303 + supplementary materials.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.xphs.2024.08.025
    • Vancouver

      Borges BA, Reis K de S, Pinto CB, Ellena J, Doriguetto AC, Bonfilio R. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate [Internet]. Journal of Pharmaceutical Sciences. 2024 ; No 2024( 11): 3297-3303 + supplementary materials.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.xphs.2024.08.025
  • Source: Journal of Pharmaceutical Innovation. Unidade: IFSC

    Subjects: PLANEJAMENTO DE FÁRMACOS, ANTIFÚNGICOS, CRISTALOGRAFIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Cecilia C. P. et al. 5-fluorocytosine/5-fluorouracil drug-drug cocrystal: a new development route based on mechanochemical synthesis. Journal of Pharmaceutical Innovation, v. 14, n. 1, p. 50-56, 2019Tradução . . Disponível em: https://doi.org/10.1007/s12247-018-9333-1. Acesso em: 03 jan. 2026.
    • APA

      Silva, C. C. P., Melo, C. C., Souza, M. S., Diniz, L. F., Carneiro, R. L., & Ellena, J. (2019). 5-fluorocytosine/5-fluorouracil drug-drug cocrystal: a new development route based on mechanochemical synthesis. Journal of Pharmaceutical Innovation, 14( 1), 50-56. doi:10.1007/s12247-018-9333-1
    • NLM

      Silva CCP, Melo CC, Souza MS, Diniz LF, Carneiro RL, Ellena J. 5-fluorocytosine/5-fluorouracil drug-drug cocrystal: a new development route based on mechanochemical synthesis [Internet]. Journal of Pharmaceutical Innovation. 2019 ; 14( 1): 50-56.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1007/s12247-018-9333-1
    • Vancouver

      Silva CCP, Melo CC, Souza MS, Diniz LF, Carneiro RL, Ellena J. 5-fluorocytosine/5-fluorouracil drug-drug cocrystal: a new development route based on mechanochemical synthesis [Internet]. Journal of Pharmaceutical Innovation. 2019 ; 14( 1): 50-56.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1007/s12247-018-9333-1

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026